Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × sonidegib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 7 Medulloblastoma 5 Skin Neoplasms 3 Recurrence 3 Basal Cell Nevus Syndrome 3 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Primary Myelofibrosis 2 Polycythemia Vera 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Thrombocytosis 1 Stomach Neoplasms 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Diseases 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Neuroepithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Fulvestrant 17 Letrozole 7 Capecitabine 5 Anastrozole 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Paclitaxel 3 Goserelin 3 sacituzumab govitecan 2 exemestane 2 eribulin 2 Vinorelbine 2 Trastuzumab 2 FCN-437c 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sonidegib 1 ribociclib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 entinostat 1 elacestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02027376 2023-04-03

EDALINE

Spanish Breast Cancer Research Group

Phase 1 Completed

12 enrolled 16 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡